悦康药业筹划发行H股股票并在香港联交所上市

Core Viewpoint - Yuyuan Pharmaceutical plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its competitive edge and international brand image while diversifying its financing channels [1] Summary by Relevant Sections - Company Strategy - The company aims to improve its overall competitiveness and international brand image through the planned listing [1] - The move is intended to better utilize international capital markets [1] - Financial Activities - The company is actively discussing the issuance of H-shares and the listing process with relevant intermediaries [1] - Specific details regarding the H-share issuance and listing have not yet been finalized [1]